Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00146887
Other study ID # 21-03.09.04-HMO-CTIL
Secondary ID Non applicable
Status Recruiting
Phase N/A
First received September 4, 2005
Last updated November 6, 2006
Start date January 2005
Est. completion date August 2005

Study information

Verified date August 2005
Source Hadassah Medical Organization
Contact Ronen Durst, MD
Phone 972-2-6777111
Email durst@cc.huji.ac.il
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

The purpose of the trial is to investigate the accuracy of coronary CT compared to the conventional "gold standard" cardiac catheterization.


Description:

40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount Scopus and Ein Kerem. Patients will be excluded if they have one or more of the following conditions

1. CABG or stent implantation in the past.

2. Atrial fibrillation

3. Contraindication for beta blockers

1. Obstructive pulmonary disease

2. Severe peripheral vascular disease

3. Sick sinus syndrome or AV block greater than 1st degree.

4. Systolic blood pressure below 100 mm Hg.

4. Renal disease or other conditions that might increase the risk of contrast nephropathy (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)

5. Allergy to contrast material.

Coronary CT angiography: Patient preparation and data acquisition Pre-procedure preparation: Following informed consent, patients will be scheduled to undergo coronary CT angiography within 7 days prior to coronary angiogram. Patients with heart rates above 75 BPM's will be given 25 mg of metoprolol P.O. 60-90 minutes before the test. If the patient does not reach heart rate below 75, administration of additional IV metoprolol may be considered by a cardiologist.

Scanning protocol: Images will be obtained using collimation of 16x0.75 mm, slice thickness 1 mm reconstructed at increments of 0.5 mm, rotation time 0.42 seconds, kVp 140 and mAs 400. Prior to scanning, 120-150cc of non-ionic contrast material will be injected to a peripheral vein at a rate of 4-5mm/sec. Images will be obtained with ECG gating.

Post processing: The Cardiac CT Angiography software (Philips, Cleveland, USA) allows extraction of the coronary tree from the heart and analysis of the arterial lumen. This application operates on the volume rendered image of the heart. After isolation of the coronary tree, the software enables the selection of an artery for quantitative analysis of its lumen. The obtained information includes presentation of the artery in panoramic views, visualization of the artery and adjacent vascular anatomy in Maximum Intensity Projection (MIP) mode for anatomical enhancement, and cross sectional views, perpendicular to the artery axis for free lumen/diameter analysis, thus providing a tool to estimate stenosis severity and dimensions. Using color mapping, plaque composition is delineated to distinguish calcified from soft plaque.

The Cardiac Review software (Philips, Cleveland, USA) provides detailed views of the patient's cardiac cycle and, using Cine function, allows dynamic viewing of the heart. Using the scanning protocol specified above, cardiac image raw data and an ECG signal are recorded simultaneously. The images are then reconstructed retrospectively in phases. Phases are defined according to the percentage of cardiac contraction, and a series of images is named according to the phase during which they are acquired. The heart can be viewed in any desired cut plane, using the Multi-Planar Formatting (MPR) application.

The Cardiac Review software provides 2 modes of viewing the heart images (Multi Views):

- Equal phase mode (multi-position), which allows viewing of a number of different cuts of the heart, all at the same cardiac phase

- Equal position mode (multi-phase), which allows viewing of the same cuts of the heart in different phases The Cardiac Axes Positioning feature provides an easy way to orient the heart to common cardiac views, including short axis, vertical long axis and horizontal axis.

The Cine feature allows viewing the heart in motion. MPR allows scrolling through various portions of the heart while viewing in the cine mode. The sequence can be saved as an AVI format movie.

Angiography: Within 7 days following coronary CT angiography patients will undergo cardiac catheterization with at least the following views: anterior-posterior (AP), right anterior oblique (RAO) cranial, RAO caudal, left anterior oblique (LAO) cranial, and LAO caudal. Additional views (e.g. AP caudal and AP cranial) are at the operator's discretion.

During the hospitalization all patients will undergo echocardiography to assess wall motion abnormalities.

Image interpretation The data will be analyzed in using the following strategies

1. Basic individual transverse sections

2. Maximal intensity projections with at least 3 of the following views that are compatible with angiogram: RAO, LAO and spider

3. Multiplanar reformation.

4. Three dimensional (3D) displays.

The coronary tree will be divided into the following segments which correlate to conventional angiogram segments Proximal RCA, 2-mid RCA, 3-distal RCA and PL, 4-PDA, 5-LM, 6-proximal LAD, 7-mid LAD, 8-distal LAD, 9-largest diagonal, 10, proximal CX, 11-Distal CX, 12-largest marginal.

These segments will be evaluated by a consensus reading of a cardiologist and a radiologist for the following parameters: existence of atherosclerosis, existence of calcification, percent narrowing within the following ranges <50%, 50%-70%, 70%-90%, tight. These scorings will be used later for comparison with the angiogram results. The physicians interpreting the CT results will be blinded to the results of the angiogram.

For analysis of myocardial function, an axial image series at the mid ventricular level showing papillary muscles through the entire cardiac cycle will be performed to visually identify the maximal systolic constriction phase and diastolic phase as the images showing the largest and smallest left ventricular cavity area, respectively. The corresponding delay in milliseconds from the R peak of the ECG will be used for image reconstruction. Then, a short and a ling axis reconstructed views will be performed to be analyzed at diastole and systole using Simson's disk method to calculate cardiac function.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 2005
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount Scopus and Ein Kerem

Exclusion Criteria:

1. CABG or stent implantation in the past.

2. Atrial fibrillation

3. Contraindication for beta blockers

1. Obstructive pulmonary disease

2. Severe peripheral vascular disease

3. Sick sinus syndrome or AV block greater than 1st degree.

4. Systolic blood pressure below 100 mm Hg.

4. Renal disease or other conditions that might increase the risk of contrast nephropathy (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)

5. Allergy to contrast material.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
coronary catheterization


Locations

Country Name City State
Israel Hadassah Medical Center Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary CT sensitivity and specificity
See also
  Status Clinical Trial Phase
Recruiting NCT03427996 - Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Not yet recruiting NCT04762472 - Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Phase 4
Not yet recruiting NCT03174418 - Fluid-dynamics in Bifurcation PCI N/A
Not yet recruiting NCT03813017 - Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
Recruiting NCT05600088 - Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina N/A
Completed NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Phase 4
Completed NCT00115583 - The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries N/A
Completed NCT03149042 - Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.
Not yet recruiting NCT05540223 - Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System N/A
Completed NCT02389946 - Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions N/A
Completed NCT01234870 - Comprehensive Evaluation of Ischemic Heart Disease Using MRI Phase 2/Phase 3
Completed NCT03471611 - Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis Phase 1
Completed NCT00353795 - Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI) N/A
Enrolling by invitation NCT04810364 - HIV Infection And Evolvement of Atherosclerotic Plaque
Active, not recruiting NCT04175626 - Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Completed NCT05492084 - Personalized Risk of Rapidly Progressive Atherosclerosis
Recruiting NCT04853511 - Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability
Completed NCT03815032 - Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison N/A
Active, not recruiting NCT03129503 - Optical Coherence Tomography in Acute Coronary Syndrome
Recruiting NCT06393894 - Latvian Early Atherosclerosis Registry